Kiniksa Pharmaceuticals International PLC (KNSA)
22.03
+0.55
(+2.56%)
USD |
NASDAQ |
Nov 05, 16:00
22.03
0.00 (0.00%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Gross Profit Margin (Quarterly): 55.96% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 55.96% |
| June 30, 2024 | 61.03% |
| March 31, 2024 | 60.70% |
| December 31, 2023 | |
| September 30, 2023 | 60.63% |
| June 30, 2023 | 69.66% |
| March 31, 2023 | 68.30% |
| Date | Value |
|---|---|
| December 31, 2022 | |
| September 30, 2022 | 88.34% |
| June 30, 2022 | 67.74% |
| March 31, 2022 | 61.25% |
| December 31, 2021 | 79.37% |
| September 30, 2021 | 77.12% |
| June 30, 2021 | 67.99% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
55.96%
Minimum
Sep 2024
88.34%
Maximum
Sep 2022
68.17%
Average
67.87%
Median
Gross Profit Margin (Quarterly) Benchmarks
| OPKO Health Inc | 28.35% |
| Ligand Pharmaceuticals Inc | 93.00% |
| Organon & Co | 58.34% |
| NovaBay Pharmaceuticals Inc | 66.33% |
| Palatin Technologies Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -2.11% |
| Return on Assets | -1.73% |
| Return on Invested Capital | -2.11% |
| Profit Margin (Quarterly) | -11.31% |
| Operating Margin (Quarterly) | -8.61% |
| Return on Net Operating Assets | -11.88% |